# FDA Inspection 731062 - Vitalant - June 22, 2011

Source: https://www.keypedia.com/records/fda_inspections/vitalant/18c6dc17-c587-4167-b081-e59f0bbb0104
Source feed: FDA_Inspections

> FDA Inspection 731062 for Vitalant on June 22, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 731062
- Company Name: Vitalant
- Inspection Date: 2011-06-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1313808 - 2026-04-16](https://www.keypedia.com/records/fda_inspections/vitalant/d04e76de-d45e-45bb-9aac-3b0ce586e6bb)
- [FDA Inspection 1237997 - 2024-03-27](https://www.keypedia.com/records/fda_inspections/vitalant/98b26f89-fea6-495e-9f63-0e60f6fd5035)
- [FDA Inspection 1113278 - 2019-12-13](https://www.keypedia.com/records/fda_inspections/vitalant/97bd227a-6736-43c1-96e8-c9968f04fcff)
- [FDA Inspection 1059997 - 2018-07-11](https://www.keypedia.com/records/fda_inspections/vitalant/08770129-3031-4500-aa82-51c5fbe0fa93)
- [FDA Inspection 961499 - 2016-02-16](https://www.keypedia.com/records/fda_inspections/vitalant/2cc580e4-0d04-4ee6-9dee-16e47a276f7e)

Company: https://www.keypedia.com/companies/vitalant/81e0ae33-169a-447f-b2aa-4d3cd88c3ed9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d